Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Year: 2007
Type: article
Study design: Clinical Trial
Source: Cancer Immunology Immunotherapy
Institutions: Chiba University, RIKEN
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2026058426
